Topic: Allergan Inc.

When Pfizer (PFE) pleaded guilty to off-label marketing last year and paid a whopping $2.3 billion fine, a little-known fact later emerged - a subsidiary was actually charged with the crime and, as a result, the parent company was allowed to continue ...

Botox maker to pay $600 mln for off-label misuse

Allergan, the maker of the popular anti-wrinkle treatment Botox, said Wednesday it had agreed to pay 600 million dollars to settle a US probe into illegal marketing for so-called off-label uses.The company said in a statement it agreed to plead guilty to ...
Allergan, the maker of the popular anti-wrinkle treatment Botox, said Wednesday it had agreed to pay 600 million dollars to settle a US probe into illegal marketing for so-called off-label uses.The company said in a statement it agreed to plead guilty to ...